Related Experiment Videos
Circulating cytomegalovirus and Epstein-Barr virus-infected cells and transfusions
M Ho1
1Department of Infectious Diseases and Microbiology, Graduate School of Public Health, University of Pittsburgh, PA 15261.
Transplantation Proceedings
|December 1, 1988
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Tumor resistance to anti-mesothelin CAR-T cells caused by binding to shed mesothelin is overcome by targeting a juxtamembrane epitope.
Proceedings of the National Academy of Sciences of the United States of America·2024
Comparison of United Kingdom and United States screening criteria for detecting retinopathy of prematurity in Hong Kong.
Hong Kong medical journal = Xianggang yi xue za zhi·2023
Prevalence of lower limb venous disease in surgeons: a case study and results of a survey by the BAOMS Reconstruction Surgical Subspecialty Interest Group.
The British journal of oral & maxillofacial surgery·2021
Investigating Risk Factors for Falls among Community-Dwelling Older Adults According to WHO's Risk Factor Model for Falls.
The journal of nutrition, health & aging·2021
Demographic, Clinical, and Allocation Shifts in the US Lung Transplant Waitlist: A National SRTR Study (2012-2023).
Transplantation proceedings·2026
Global Status and Research Trends of Heart Transplantation: A Bibliometrics Analysis.
Transplantation proceedings·2026
Apoptosis-Related Molecular Signatures in Calcineurin Inhibitor Nephrotoxicity After Kidney Transplantation.
Transplantation proceedings·2026
Prognostic Role of Blood Inflammatory Composite Biomarkers in Dvt After Lower Extremity Fractures.
The Iowa orthopaedic journal·2026
Pattern of blood utilization and blood wastage at blood bank of a tertiary care hospital in Lahore.
Pakistan journal of medical sciences·2026
Coagulation potential of concomitant factor VIII administration in people with hemophilia A receiving emicizumab prophylaxis (CAGUYAMA study): a multicenter, open-label, nonrandomized clinical trial.
Research and practice in thrombosis and haemostasis·2026
Management and outcomes in patients with cryptogenic stroke and weakly positive antiphospholipid antibodies.
Research and practice in thrombosis and haemostasis·2026